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ARTICLE OPEN
Systematic review of clinical prediction models to support the
diagnosis of asthma in primary care
Luke Daines 1, Susannah McLean1, Audrey Buelo2, Steff Lewis3, Aziz Sheikh1 and Hilary Pinnock1
Diagnosing asthma is challenging. Misdiagnosis can lead to untreated symptoms, incorrect treatment and avoidable deaths. The
best combination of clinical features and tests to achieve a diagnosis of asthma is unclear. As asthma is usually diagnosed in non-
specialist settings, a clinical prediction model to aid the assessment of the probability of asthma in primary care may improve
diagnostic accuracy. We aimed to identify and describe existing prediction models to support the diagnosis of asthma in children
and adults in primary care. We searched Medline, Embase, CINAHL, TRIP and US National Guidelines Clearinghouse databases from
1 January 1990 to 23 November 17. We included prediction models designed for use in primary care or equivalent settings to aid
the diagnostic decision-making of clinicians assessing patients with symptoms suggesting asthma. Two reviewers independently
screened titles, abstracts and full texts for eligibility, extracted data and assessed risk of bias. From 13,798 records, 53 full-text
articles were reviewed. We included seven modelling studies; all were at high risk of bias. Model performance varied, and the area
under the receiving operating characteristic curve ranged from 0.61 to 0.82. Patient-reported wheeze, symptom variability and
history of allergy or allergic rhinitis were associated with asthma. In conclusion, clinical prediction models may support the
diagnosis of asthma in primary care, but existing models are at high risk of bias and thus unreliable for informing practice. Future
studies should adhere to recognised standards, conduct model validation and include a broader range of clinical data to derive a
prediction model of value for clinicians.
npj Primary Care Respiratory Medicine           (2019) 29:19 ; https://doi.org/10.1038/s41533-019-0132-z
INTRODUCTION
Making an accurate diagnosis of asthma is fundamental to
improving asthma care and outcomes. However, asthma is
commonly misdiagnosed, with over- and under-diagnosis of
asthma in children and adults reported.1–3 Over-diagnosis leads
to costly, potentially harmful treatment and unnecessary health
care, whilst under-diagnosis risks inadequate treatment and
avoidable morbidity and mortality.
Accurately diagnosing asthma is challenging. Asthma is a
heterogeneous disease comprising different genotypes, endo-
types and phenotypes.4 There is no ‘gold’ reference standard that
can categorically confirm or refute the diagnosis. Asthma is thus a
clinical diagnosis, but individual symptoms, signs and tests have
poor sensitivity/specificity for the diagnosis. Uncertainty about the
best combination of clinical features and tests for asthma
diagnosis is reflected in conflicting recommendations between
national5,6 and international7 guidelines and highlighted in
commentaries seeking to reduce confusion for clinicians.8,9
One solution could be to use a clinical prediction model, a data-
driven algorithm that combines at least two predictors, such as
elements from a clinical history, physical examination, test results
and/or response to treatment, to estimate the probability that an
outcome is present.10 Clinical prediction models can assist
healthcare professionals to weigh up the probability of a
diagnosis, enhance shared decision-making and aid patient
stratification into subtypes.11,12 As most asthma diagnoses occur
in non-specialist settings,4 where health problems typically
present in an undifferentiated manner, and assessment is often
based on probability,13 a prediction model could increase the
accuracy of asthma diagnosis by supporting the appraisal of
available clinical information and guiding next steps.
We aimed to identify, compare and synthesise existing clinical
prediction models designed to support the diagnosis of asthma in
children and adults presenting with symptoms suggestive of
asthma in primary care or equivalent settings.
RESULTS
Study selection
Our searches identified 13,798 records. Following the removal of
duplicates, 13,180 titles and abstracts were screened (Fig. 1). Fifty
three articles were reviewed in full text, with 45 articles excluded
(Supplementary Table 1). Eight articles from seven studies met the
review criteria and were included.14–21
Study characteristics
The included studies all derived new clinical prediction models
(Table 1). Each study presented a model that could be used to aid
the diagnosis of asthma; however, study rationale varied, and this
was reflected in the design and approach to modelling used. Six
studies used multivariable logistic regression to derive their
prediction models.14,15,17,18,20,21 One study developed a decision
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tree.19 Six models were derived from adults,14,17–21 and one from
children.15 The three studies14,18,21 that recruited exclusively from
out-patient departments were conducted in countries without
established primary care services, where patients commonly
presented with undifferentiated symptoms to secondary care.22,23
Risk of bias
All included studies were judged to be at high risk of bias. Bias was
introduced by various means, though certain limitations were
shared by several studies (Table 2). Most notable was the lack of
model validation. See Supplementary Note 1 for detailed risk of
bias assessment.
Model performance and validation
Three studies reported model performance using classification
measures (Table 1),15,19,21 whilst three reported model discrimina-
tion using the area under the receiver operating characteristic
curve (AUROC), which ranged from 0.61 to 0.82.14,18,20 None of the
studies reported model calibration.
Hirsch et al.17 conducted internal validation, but did not report
model performance. Metting et al.19 conducted an internal (10-
fold cross) validation and external validation of the final decision
tree using data from a different asthma/COPD referral service
within the Netherlands. Model performance (derived from
available data; no confidence intervals (CIs) available) was similar
in the derivation (sensitivity 0.79, specificity 0.75) and validation
datasets (sensitivity 0.78, specificity 0.60).19 Five studies reported
no validation, with model performance likely to be over-estimated
in these cases.14,15,18,20,21
Model presentation
Of the six studies that derived a prediction model using logistic
regression, four presented a scoring system,14,17,18,21 one a web-
based clinical calculator20 and one presented model output from
which a probability could be calculated.15 The decision tree had
six ‘branches’ of predictors that led to a probability of asthma,
though this approach limited the number of predictor
combinations.19
Model outcome measures
Four studies based their outcome measure on bronchial challenge
testing;14,18,20,21 an asthma diagnosis was indicated by a 20% fall
in forced expiratory volume in 1 s (FEV1) from baseline after
stepwise inhalation of methacholine up to a maximum 8mg/ml 21
or 16 mg/ml.14,18,20
Expert opinion informed the outcome in two studies.17,19 Hirsch
et al.17 used a panel of three experts, whilst Metting et al.19 used
one of ten respiratory specialists to make a diagnosis. In one study,
healthcare providers made an asthma diagnosis when a child
demonstrated reversible episodic symptoms, indicated by spiro-
metry or symptom resolution.15
Description of predictor variables
The clinical prediction models combined between 4 (ref. 15) and
22 (ref. 19) predictors to estimate the probability of asthma. Three
studies collected data from questionnaires only.14,15,18 The
remaining studies collected a wider range of clinical data, though
not all of the information was included in model development
(Table 3). Figure 2 illustrates the strength of association between
predictors included in the prediction models and the outcome,
asthma. The most common predictors were wheeze, cough,
symptom variability and allergy. Estimates for individual predictors
were unavailable from two studies.17,19
Participant age was collected in all studies, but only considered
in the model development of two studies.17,20 The decision tree
used age of onset of respiratory symptoms in five of six
branches.19 Male sex was associated with asthma in one model.17
Wheeze as a symptom was used in five clinical prediction
models,14,15,17–19 though six different questions were used.
Despite wide variation in how wheeze was recorded between
studies, the magnitude of association between wheeze variables
and asthma outcome were similar (Fig. 2) in four of five studies.
The exception was Hall et al.15 whose reported estimates were
much greater than other studies.
Cough was included in five of seven prediction models and
asked about in three different ways (Fig. 2).14,15,17,18,20 Variables for
cough were not clearly predictive for asthma in four stu-
dies.14,17,18,20 In contrast, Hall et al.15 reported that a cough
lasting beyond 10 days after a cold was associated with asthma
(odds ratio (OR) 5.8 (outpatients); OR 3.1 (primary care), CIs not
reported), despite cough in children commonly taking over
10 days to settle.24
Respiratory tract infection was included in four prediction
models, though was of unclear value as all studies were judged at
high risk of bias.14,17,18,20
Being woken by chest tightness was associated with asthma in
one study.17 Waking up because of cough in the past year was
associated with asthma in one study at high risk of bias, though
the lack of CIs makes the precision of estimates unclear.15
Symptoms disturbing sleep were not predictive in two other
models.19,20
Episodic symptoms and diurnal variation were associated with
asthma in one study,21 yet Choi et al.14 found ‘fluctuation of
exacerbation and improvement’ was not associated with asthma
(OR 1.24, 95% CI 0.75–2.05). Exercise-induced symptoms were
associated with asthma in three studies.14,15,18 However, ‘dys-
pnoea on exertion’ was not significant in one study.20
The presence of allergy/atopic disease was predictive of asthma
in five studies.17–21 Five of six decision tree branches included the
presence/absence of allergy;19 past allergic disease, respiratory
symptoms triggered by aeroallergens/pollutants and nasal allergy
were significantly associated with asthma (Fig. 2).18,20,21
Current use of asthma medication was asked about and
valuable in two studies,17,20 whilst past asthma attack was
recorded by one study.17
Fig. 1 Preferred Reporting Items for Systematic Review and Meta-
Analysis (PRISMA) flow diagram
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Participants who smoked scored ‘−1’ in the prediction model
by Hirsch et al.17 ‘never smoked’ and a ratio of FEV1 by forced vital
capacity (FEV1/FVC) <70%, formed one of six decision tree
branches leading to asthma.19 Four studies collected smoking
data, but did not include it in their analysis.14,18,20,21
Family history of asthma was included by one study,17 but
having a ‘close relative with allergic diseases’ was not associated
with asthma in another (OR 1.19, 95% CI 0.73–1.93).21
Only Tomita et al.21 incorporated information from clinical
examination. Wheeze heard on auscultation was associated with
asthma (OR 3.68, 95% CI 1.78–7.62).21
FEV1/FVC was included in all branches that led to asthma in the
decision tree.19 Bronchodilator reversibility was used in four out of
six branches, though in contrast to guideline recommendations,5–7
two branches included reversibility of <7%.19 Schneider et al.20
included fractional exhaled nitric oxide (FeNO) as the main
predictor in their clinical prediction models. Tomita et al21
collected relevant data but did not include in model development.
DISCUSSION
This systematic review identified seven clinical prediction models
to support the diagnosis of asthma in primary care. All studies
were judged to be at high risk of bias and cannot be
recommended for diagnosing asthma in routine clinical practice.
Wheeze, allergy, allergic rhinitis, symptom variability and exercise-
induced symptoms were associated with asthma and should be
considered as predictors in future prediction models. Cough,
respiratory tract infection and nocturnal respiratory symptoms
were inconsistently associated with asthma.
The use of Checklist for critical Appraisal and data extraction for
systematic Reviews of prediction Modelling Studies (CHARMS) and
Prediction model Risk Of Bias ASsessment Tool (PROBAST),
systematic review frameworks specific for prediction models, in
undertaking this review ensured each step was conducted to
international standards. PROBAST was yet to be published, but we
used it for risk of bias assessment as it was purposefully developed
for reviews of prediction models by the Cochrane Prognosis
Group, and had been successfully piloted.25,26 We reduced the
possibility of reporting bias by duplicate, independent data
extraction and risk of bias assessment. We planned to evaluate
the overall quality of evidence using the Grading of Recommen-
dations Assessment, Development and Evaluation (GRADE)
system. Originally designed for reviews of intervention studies,
GRADE has been adapted for reviews of prognostic studies,
though not specifically for prediction models.27,28 Consequently,
in its current form we did not find GRADE to be a suitable tool for
our systematic review and decided not to use it. Future research
should consider how to adapt GRADE so that it can be used for
reviews of clinical prediction models.
We searched databases from 1 January 1990, having found no
relevant literature before this date in preliminary searches. Our
decision to search five databases was informed by the strategies
of similar systematic reviews,29,30 but despite this we may have
missed some relevant studies.
Restricting the population of interest to primary care (or
equivalent) populations limited the number of studies we could
include. Asthma may be diagnosed in both primary and secondary
care, and current guidelines present diagnostic algorithms
irrespective of clinical setting.5–7 However, the diagnostic value
of symptoms, signs and tests vary depending on the setting in
which they are used,31 and the general approach to making a
diagnosis differs, as secondary care tend to see referred patients.13
As most diagnoses occur in non-specialist settings,4 we opted to
focus on clinical prediction models derived from primary care
participants. The degree to which study participants presented
with undifferentiated symptoms was unclear in some studies. We
sought additional information about the country of origin and
made decisions based on team discussion to mitigate this
uncertainty.
National and international guidelines are consistent in their
advice to build up evidence to support a diagnosis of asthma
based on history, examination, investigations and when necessary,
a monitored trial of treatment.5–7 The Global Initiative for Asthma
describes a characteristic pattern of symptoms (wheezing, short-
ness of breath, cough, chest tightness varying over time and in
intensity) as indicative of asthma.7 Our included clinical prediction
models endorse wheeze and symptom variability as potentially
valuable predictors; however, cough and breathlessness were
inconsistently associated with asthma. This inconsistency may in
part have arisen from the different ways in which predictors were
defined. For example, participants were asked about coughs that
were variously ‘paroxysmal’, ‘nocturnal’, ‘daytime’, ‘often’ in the
different studies limiting the comparison between prediction
models and preventing meta-analysis. Additionally, patients and
parents understand and describe symptoms differently from
clinicians (and researchers),32 and future studies should choose
reliable terms when phrasing questions about symptoms.33
Another reason for the inconsistent association between
predictors and asthma observed in the included studies may be
the imperfect nature of the outcome measure (reference standard)
available for asthma. There is no universally accepted method to
deal with an imperfect reference standard.34 Subsequently, in
asthma diagnostic research it is not uncommon for different
reference standards to be used between studies. For instance, in a
systematic review reporting the accuracy of FeNO for asthma
Table 2. Critical appraisal of the seven selected prediction modelling studies based on the PROBAST checklist25
Study ID Risk of bias Applicability Overall
Participant selection Predictors Outcome Analysis Participant selection Predictors Outcome Risk of Bias Applicability
Choi 2007 ? ? ? – ? + + – ?
Hall 2001 – ? – ? – + – – –
Hirsch 2001/2004 – + – – – + – – –
Lim 2014 – ? – ? ? + ? – ?
Metting 2016 + + – – – + + – –
Schneider 2015 + + ? – + + + – +
Tomita 2013 + ? – – – + + – –
(+)= low risk of bias or applicability concern, (?)= unclear risk of bias or applicability concern, (–)= high risk of bias or applicability concern
PROBAST Prediction model Risk Of Bias ASsessment Tool
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diagnosis, included studies were found to have substantial
heterogeneity in the reference standards used.35 In this review,
four studies used methacholine bronchial provocation, considered
to be the best available reference standard for asthma, though it is
known to be better at ruling out, rather than ruling in the
diagnosis.36 The remaining studies used clinician judgement to
classify those with/without asthma, a valid solution in the face of
an imperfect reference standard,34 but highly dependent on the
performance, consistency and agreement of the clinicians.
Understanding that the performance of a prediction model for
asthma diagnosis depends so heavily on the outcome measure
chosen, future studies should consider recommendations to move
away from the umbrella term ‘asthma’, instead focussing on
identifying ‘treatable traits’ as failure to recognise asthma as an
aggregate diagnosis is likely to limit any improvement in
diagnostic accuracy gained from a clinical prediction model.4,37
This review highlights the paucity of current evidence to inform
diagnostic algorithms. A validated clinical prediction model for
asthma diagnosis could help healthcare professionals improve the
accuracy of a diagnosis by guiding decision-making and reducing
variability between clinicians. That only two studies considered
diagnostic tests as candidate predictors was disappointing given
the potential for prediction models to combine information from a
clinical history, physical examination and tests. Failure to confirm
the presence of asthma with objective tests has been implicated
in the widespread misdiagnosis.1 So, on a practical level, a
validated prediction model that guides a clinician in the questions
to ask, and the test(s) required to confirm or refute an asthma
diagnosis, is likely to be most useful.
Future attempts at model derivation for asthma diagnosis
should be informed by recognised standards such as the
Transparent Reporting of a multivariable prediction model for
Individual Prognosis Or Diagnosis (TRIPOD).38 Prediction models
should undergo internal and external validation and report model
performance using calibration and discrimination measures.39 In
this review, none of the included studies reported model
calibration. Model validation was completed by only two studies,
a finding that matches the wider literature.40 Finally, strategies to
implement the validated model in routine clinical practice need to
be developed, piloted and evaluated,41 to assess impact on clinical
outcomes.40
In conclusion, existing clinical prediction models to support
clinicians in making a diagnosis of asthma in primary care are at
high risk of bias and thus of limited clinical value. Wheeze,
symptom variability and the presence of other allergic disease
were associated with asthma diagnosis. Informed by this review,
future studies should address the limitations identified and follow
established methods to derive and validate a prediction model of
Table 3. Predictors considered in each of the seven included prediction modelling studies
Predictors Choi Hall Hirsch Lim Metting Schneider Tomita
Patient demographics
Age x x ✓ x ✓ ✓ x
Sex x x ✓ x △ △ x
Weight/height/body mass index x – – x △ – x
Symptoms
Wheeze ✓ ✓ ✓ ✓ ✓ ✓ ✓
Cough ✓ ✓ – – – ✓ –
Night cough – ✓ ✓ ✓ – – –
Breathlessness ✓ – ✓ – △a △ –
Respiratory infection ✓ – – ✓ – ✓ –
Symptoms disrupting sleep – – ✓ – △a △ –
Symptom variability ✓ – – – – – ✓
Exercise-induced symptoms ✓ ✓ – ✓ – △ Xa
Allergeninduced symptoms – – – ✓ – – –
Medical history
Smoking x – ✓ x ✓ △ x
History of allergy or atopy – x ✓ – ✓ ✓ ✓
Family history of allergy or atopy – x – – △ – ✓
History of asthma/attack – x ✓ – – – –
Asthma medication use – x ✓ – △a ✓ –
Family history of asthma – x ✓ – △ – –
Findings from clinical examination and investigation
Wheeze on auscultation – – – – – – ✓
Lung function – – – – ✓ – x
Fractional exhaled nitric oxide – – – – – ✓ x
Blood eosinophils – – – – – – x
Serum IgE – – – – – – x
Predictors are grouped to demonstrate commonalities between clinical prediction models. Each study constructed variables using different questions/
measurements (Supplementary Table 3). (✓)= predictor included in final clinical prediction model. (△)= predictor not in final prediction model: excluded
during modelling. (x)= predictor not in final prediction model: excluded before modelling. (–)= predictor was not measured/collected
a Information was incorporated within a validated asthma questionnaire, but not analysed separately
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6
npj Primary Care Respiratory Medicine (2019)    19 Published in partnership with Primary Care Respiratory Society UK
value to clinicians. Establishing a data-driven approach to asthma
diagnosis could resolve current discrepancies in guidelines and
enable the unacceptable level of asthma misdiagnosis to be
reduced.
METHODS
The systematic review was registered with PROSPERO (CRD42018078418).
Detailed methods were described in the published protocol,42 with salient
points presented here. We followed the CHARMS39 and Preferred
Reporting Items for Systematic Review and Meta-Analysis (PRISMA).43
Study eligibility criteria
Population. Children or adults presenting with symptoms suggestive of
asthma in primary care.
Intervention. Any clinical prediction model designed to aid the diagnostic
decision-making of a healthcare professional during the assessment of an
individual with symptoms suggestive of asthma.
Comparator. Not applicable.
Outcome. The primary outcome to be predicted was the probability of an
asthma diagnosis. We included studies that presented a prediction model,
or equivalent statistical method, that allowed the probability of asthma to
be calculated for an individual. To be included, the study had to use an
outcome based on an internationally recognised definition for asthma (as
available, for instance, from the Global Initiative for Asthma.7)
Timing. Any diagnostic prediction model that provides an estimate for
the probability that asthma is present at the time of clinical assessment.
Setting. We included any clinical prediction model designed for use in a
primary care population or equivalent (defined as any setting where
undifferentiated health problems are presented to healthcare professionals).13
Study type. We included prediction model derivation studies (with or
without external validation) and external model validation studies.39
Randomised controlled trials, cohort studies (prospective or retrospective),
cross-sectional, nested case–control and case–cohort studies were eligible
for inclusion.39
Exclusion criteria
Studies were excluded if:
1. Variables were not combined to produce a diagnostic estimate
2. Publication occurred before 1 January 1990 (preliminary searches
identified no relevant citations before this date)
3. Variables used in the clinical prediction model were not clearly
reported, or unavailable in routine clinical practice (for example
genetic tests)
4. Separate outcomes for asthma were not reported or the asthma
outcome was not extractable
5. The prediction model was derived to predict the future risk of asthma
6. Over half of study participants were children <5 years old (because of
the overlap between asthma and viral associated wheeze in this age
group)
7. Non-original studies such as editorials, expert views.
Fig. 2 Forest plots demonstrating the strength of association of predictor variables against the outcome asthma. Not all studies had
extractable data. PP= private practice, Co= combined dataset (private practice and primary care), OPD= out-patient department, PC=
primary care. Confidence intervals were not reported for all estimates, indicated by [NR]. No overall estimates were produced as meta-analysis
was not possible
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Information sources and search strategy
We searched Medline, Embase, CINAHL, TRIP (https://www.tripdatabase.com)
and US National Guidelines Clearinghouse (https://www.guideline.gov)
databases from 1 January 1990 to 23 November 2017. The search strategy
(Supplementary Table 2) combined published searches for prediction
models44,45 with Cochrane Airways asthma search terms.46 Forward and
backward citation searching was completed. No language restrictions were
used. Studies were translated when necessary.
Study selection
Retrieved records were de-duplicated, screened and managed using
Covidence (https://www.covidence.org). Two reviewers (L.D., A.B.) inde-
pendently screened titles and abstracts. Full-text copies of all relevant
records were obtained. Two reviewers (L.D., S.McL.) independently
assessed each full-text record for eligibility. Discrepancies were arbitrated
by discussion (H.P., S.L. and A.S.).
Data collection process
A standardised data extraction form was developed using CHARMS and
piloted.39 Two reviewers (L.D., S.McL.) independently extracted data from
included studies, with disagreements resolved by third reviewer (H.P., S.L.
or A.S.). Study authors were contacted if further information or clarification
was required. Data were summarised in descriptive tables (Supplementary
Table 3).
Critical appraisal of individual studies
Two reviewers (L.D., S.McL.) used the PROBAST to independently evaluate
risk of bias and concerns about applicability before reaching a consensus
for each included study.25 According to PROBAST, risk of bias assessment is
guided by 20 signalling questions across four domains; participant
selection, predictors, outcome and analysis. Each domain is scored low,
high or unclear risk of bias and combined to provide an assessment for
each study. If a study scores high risk of bias for any domain, PROBAST
advises the study to be rated high risk of bias overall. The extent to which
each study matched the review question was assessed using PROBAST
applicability concern questions. Three domains were assessed; participant
selection, predictors and outcome, leading to an overall rating for
applicability.
Data synthesis and summary measures
Results were summarised by narrative synthesis as between-study
heterogeneity precluded meta-analyses. We summarised the final model
presentation and available measures of overall performance, including
calibration, discrimination and classification parameters, from each
included study. We appraised the strength of association of predictors
used in each model against the outcome (asthma) by comparing
regression coefficients and odds ratios.
Evaluating confidence in cumulative evidence
We planned to report the overall quality of evidence using GRADE.
However, in a change from our protocol, we decided to omit the use of
GRADE, as without an adaptation for prediction modelling studies, we did
not find it to be a suitable tool.27 Assessment of publication bias was not
completed due to heterogeneity between studies.
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